To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
Clinical trial NCT02977065 · COMPLETED
Trial details
- NCT number
- NCT02977065
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-23
- Primary completion
- 2017-12-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.